RiverPoint Capital Management LLC Has $2.15 Million Position in Walgreens Boots Alliance, Inc. (WBA)

RiverPoint Capital Management LLC decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 27,452 shares of the pharmacy operator’s stock after selling 2,228 shares during the quarter. RiverPoint Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $2,150,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the stock. Federated Investors Inc. PA raised its stake in Walgreens Boots Alliance by 9.9% in the 2nd quarter. Federated Investors Inc. PA now owns 407,565 shares of the pharmacy operator’s stock valued at $31,917,000 after purchasing an additional 36,773 shares during the last quarter. Mosaic Family Wealth LLC raised its stake in Walgreens Boots Alliance by 4.1% in the 2nd quarter. Mosaic Family Wealth LLC now owns 10,194 shares of the pharmacy operator’s stock valued at $798,000 after purchasing an additional 401 shares during the last quarter. Truepoint Inc. raised its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Truepoint Inc. now owns 8,614 shares of the pharmacy operator’s stock valued at $698,000 after purchasing an additional 39 shares during the last quarter. Cadence Capital Management LLC raised its stake in Walgreens Boots Alliance by 0.7% in the 2nd quarter. Cadence Capital Management LLC now owns 14,951 shares of the pharmacy operator’s stock valued at $1,171,000 after purchasing an additional 111 shares during the last quarter. Finally, Boston Private Wealth LLC raised its stake in Walgreens Boots Alliance by 1.8% in the 2nd quarter. Boston Private Wealth LLC now owns 176,324 shares of the pharmacy operator’s stock valued at $13,808,000 after purchasing an additional 3,172 shares during the last quarter. 60.14% of the stock is owned by hedge funds and other institutional investors.

Shares of Walgreens Boots Alliance, Inc. (WBA) opened at 67.74 on Thursday. Walgreens Boots Alliance, Inc. has a one year low of $67.40 and a one year high of $89.69. The stock’s 50 day moving average price is $77.18 and its 200-day moving average price is $80.29. The stock has a market cap of $72.49 billion, a PE ratio of 17.11 and a beta of 1.25.

Walgreens Boots Alliance declared that its Board of Directors has authorized a share buyback plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to purchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 13.50% of the stock is currently owned by company insiders.

WBA has been the subject of several analyst reports. Morgan Stanley reissued an “overweight” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. SunTrust Banks, Inc. set a $72.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Sunday. Finally, Royal Bank Of Canada initiated coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price objective for the company. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $90.18.

COPYRIGHT VIOLATION NOTICE: “RiverPoint Capital Management LLC Has $2.15 Million Position in Walgreens Boots Alliance, Inc. (WBA)” was first published by The Ledg

A number of other hedge funds have also recently made changes to their positions in the stock. Federated Investors Inc. PA raised its stake in Walgreens Boots Alliance by 9.9% in the 2nd quarter. Federated Investors Inc. PA now owns 407,565 shares of the pharmacy operator’s stock valued at $31,917,000 after purchasing an additional 36,773 shares during the last quarter. Mosaic Family Wealth LLC raised its stake in Walgreens Boots Alliance by 4.1% in the 2nd quarter. Mosaic Family Wealth LLC now owns 10,194 shares of the pharmacy operator’s stock valued at $798,000 after purchasing an additional 401 shares during the last quarter. Truepoint Inc. raised its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Truepoint Inc. now owns 8,614 shares of the pharmacy operator’s stock valued at $698,000 after purchasing an additional 39 shares during the last quarter. Cadence Capital Management LLC raised its stake in Walgreens Boots Alliance by 0.7% in the 2nd quarter. Cadence Capital Management LLC now owns 14,951 shares of the pharmacy operator’s stock valued at $1,171,000 after purchasing an additional 111 shares during the last quarter. Finally, Boston Private Wealth LLC raised its stake in Walgreens Boots Alliance by 1.8% in the 2nd quarter. Boston Private Wealth LLC now owns 176,324 shares of the pharmacy operator’s stock valued at $13,808,000 after purchasing an additional 3,172 shares during the last quarter. 60.14% of the stock is owned by hedge funds and other institutional investors.

Shares of Walgreens Boots Alliance, Inc. (WBA) opened at 67.74 on Thursday. Walgreens Boots Alliance, Inc. has a one year low of $67.40 and a one year high of $89.69. The stock’s 50 day moving average price is $77.18 and its 200-day moving average price is $80.29. The stock has a market cap of $72.49 billion, a PE ratio of 17.11 and a beta of 1.25.

Walgreens Boots Alliance declared that its Board of Directors has authorized a share buyback plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to purchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 13.50% of the stock is currently owned by company insiders.

WBA has been the subject of several analyst reports. Morgan Stanley reissued an “overweight” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. SunTrust Banks, Inc. set a $72.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Sunday. Finally, Royal Bank Of Canada initiated coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price objective for the company. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $90.18.

COPYRIGHT VIOLATION NOTICE: “RiverPoint Capital Management LLC Has $2.15 Million Position in Walgreens Boots Alliance, Inc. (WBA)” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://ledgergazette.com/2017/10/19/riverpoint-capital-management-llc-has-2-15-million-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply